Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P B Tracy

Showing results (31-40 of 65) with videos related to

Pageof 7
Sort By:
Biochemistry|January 6, 1981
Molecular weight of undegraded plasma factor VK G Mann, M E Nesheim, P B Tracy
Hospital Practice (1995)|June 2, 1998
Acute coronary syndromes: 2. Antiplatelet agentsD J Schneider, P B Tracy, B E Sobel
Methods in Enzymology|January 1, 1992
Platelet factor Xa receptorP B Tracy, M E Nesheim, K G Mann
The Journal of Biological Chemistry|September 20, 1996
An antifibrinolytic mechanism describing the prothrombotic effect associated with factor VLeidenL Bajzar, M Kalafatis, P Simioni, et al.
Journal of Thrombosis and Haemostasis : JTH|May 29, 2013
Proteolysis of plasma-derived factor V following its endocytosis by megakaryocytes forms the platelet-derived factor V/Va poolF Ayombil, S Abdalla, P B Tracy, et al.
Blood|October 27, 1998
Secretable human platelet-derived factor V originates from the plasma poolR M Camire, E S Pollak, K Kaushansky, et al.
Methods in Enzymology|January 1, 1981
Factor VM E Nesheim, J A Katzmann, P B Tracy, et al.
Circulation|December 31, 1997
Differential effects of anticoagulants on the activation of platelets ex vivoD J Schneider, P B Tracy, K G Mann, et al.
Blood|May 16, 1998
Platelet-derived factor Va/Va Leiden cofactor activities are sustained on the surface of activated platelets despite the presence of activated protein CR M Camire, M Kalafatis, P Simioni, et al.
Obstetrics and Gynecology|March 10, 1998
Adenosine diphosphate-induced platelet activation inhibited by magnesium in a dose-dependent mannerW L Leaphart, M C Meyer, E L Capeless, et al.
Pageof 7

Showing results (31-40 of 65) with videos related to

Sort By:
Pageof 7
Biochemistry|January 6, 1981
Molecular weight of undegraded plasma factor VK G Mann, M E Nesheim, P B Tracy
Hospital Practice (1995)|June 2, 1998
Acute coronary syndromes: 2. Antiplatelet agentsD J Schneider, P B Tracy, B E Sobel
Methods in Enzymology|January 1, 1992
Platelet factor Xa receptorP B Tracy, M E Nesheim, K G Mann
The Journal of Biological Chemistry|September 20, 1996
An antifibrinolytic mechanism describing the prothrombotic effect associated with factor VLeidenL Bajzar, M Kalafatis, P Simioni, et al.
Journal of Thrombosis and Haemostasis : JTH|May 29, 2013
Proteolysis of plasma-derived factor V following its endocytosis by megakaryocytes forms the platelet-derived factor V/Va poolF Ayombil, S Abdalla, P B Tracy, et al.
Blood|October 27, 1998
Secretable human platelet-derived factor V originates from the plasma poolR M Camire, E S Pollak, K Kaushansky, et al.
Methods in Enzymology|January 1, 1981
Factor VM E Nesheim, J A Katzmann, P B Tracy, et al.
Circulation|December 31, 1997
Differential effects of anticoagulants on the activation of platelets ex vivoD J Schneider, P B Tracy, K G Mann, et al.
Blood|May 16, 1998
Platelet-derived factor Va/Va Leiden cofactor activities are sustained on the surface of activated platelets despite the presence of activated protein CR M Camire, M Kalafatis, P Simioni, et al.
Obstetrics and Gynecology|March 10, 1998
Adenosine diphosphate-induced platelet activation inhibited by magnesium in a dose-dependent mannerW L Leaphart, M C Meyer, E L Capeless, et al.
Pageof 7